Lindbrook Capital’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.54K Hold
892
﹤0.01% 2212
2024
Q4
$5.23K Hold
892
﹤0.01% 1965
2024
Q3
$3.98K Sell
892
-382
-30% -$8.96K ﹤0.01% 2106
2024
Q2
$33.8K Hold
1,274
﹤0.01% 968
2024
Q1
$34.9K Buy
1,274
+300
+31% +$9.52K ﹤0.01% 935
2023
Q4
$23.7K Hold
974
﹤0.01% 1091
2023
Q3
$19.7K Sell
974
-167
-15% -$4.28K ﹤0.01% 1067
2023
Q2
$33.7K Hold
1,141
﹤0.01% 850
2023
Q1
$28.5K Hold
1,141
﹤0.01% 917
2022
Q4
$36.2K Sell
1,141
-551
-33% -$17.4K ﹤0.01% 814
2022
Q3
$50K Sell
1,692
-650
-28% -$22.4K 0.01% 640
2022
Q2
$71K Sell
2,342
-75
-3% -$6.87K 0.01% 539
2022
Q1
$326K Buy
2,417
+95
+4% +$10K 0.05% 214
2021
Q4
$303K Buy
2,322
+819
+54% +$104K 0.05% 229
2021
Q3
$141K Sell
1,503
-2,511
-63% -$256K 0.04% 213
2021
Q2
$411K Buy
4,014
+1,521
+61% +$266K 0.09% 91
2021
Q1
$459K Sell
2,493
-210
-8% -$46.3K 0.1% 78
2020
Q4
$926K Buy
2,703
+1,145
+73% +$270K 0.23% 39
2020
Q3
$288K Buy
+1,558
New +$260K 0.08% 98

Other funds holding LONA

Lindbrook Capital's LONA Position: Q1 2025 in Review

Lindbrook Capital held its LeonaBio Inc (LONA) position steady in Q1 2025 at 892 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

Lindbrook Capital first reported a position in LONA in Q3 2020 and has held it in 19 quarters since. The position peaked at $926K in Q4 2020. 53 funds tracked by Wall St. Rank hold LONA as of Q1 2025.

  • Lindbrook Capital held 892 shares of LeonaBio Inc worth $2.54K as of Q1 2025.
  • Lindbrook Capital left its LeonaBio Inc share count unchanged in Q1 2025.
  • LeonaBio Inc made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2212 holding.
  • Lindbrook Capital first reported a position in LeonaBio Inc in Q3 2020 and has held it in 19 quarters since.
  • Lindbrook Capital's LeonaBio Inc position peaked at $926K in Q4 2020.
  • 53 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.